Product logins

Find logins to all Clarivate products below.


Biosurgical Agents | Market Insights | Japan | 2024

The Japanese biosurgical agent market will exhibit moderate growth over the forecast period. Growth over the forecast period will be driven by continuing growth of procedures in which in biosurgical agents are used, rising awareness of the clinical benefits of these products on surgical outcomes, and the expanded indications in multiple procedures.

This Medtech 360 Report provides comprehensive data and analysis on the state of the biosurgical agent market in Japan from 2019 through 2032.

Related Medtech Insights Reports

Report
Sports Medicine Devices – Market Insights – Japan
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, improved surgeon training, and high levels of sports participation will…
Report
Large-Joint Reconstructive Implants – Market Insights – Japan
Growth in large-joint reconstructive procedure volumes is being driven by favorable demographic trends and increased demand for innovative technologies. However, market expansion is partly…
Report
Trauma Devices – Market Insights – Japan
The Japanese trauma device market will experience marginal growth through 2034, primarily fueled by the adoption of innovative, premium-priced technologies. This upward trend is further supported…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Japan
The Japanese GI endoscopy device market is projected to experience modest expansion through 2034. This growth is driven by favorable treatment and screening guidelines, as well as an aging…